Jacob Sands

13PUBLICATIONS
120CO-AUTHORS
Cancer geneticsPredictive and prognostic markersRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Apr 30, 2026
A Longitudinal Comprehensive Biospecimen and Clinical Data Repository for Cancer Early Detection: The InAdvance Study.

|Apr 17, 2026
Transcription Factor Subtype Governs Response and Resistance to DLL3-Directed T-Cell Engagement in Small Cell Lung Cancer.

|Aug 26, 2025
Clinical strategies for lung cancer management: Recommendations from the Bridging the Gaps Lung Cancer Consensus Conference 2024.

Narjust Florez, Sandip Patel, Heather A Wakelee

|Jul 11, 2025
Stereotactic Radiosurgery in Patients With Small Cell Lung Cancer and 1-10 Brain Metastases: A Multi-Institutional, Phase II, Prospective Clinical Trial.

Ayal A Aizer, Shyam K Tanguturi, Diana D Shi

|Jun 11, 2025
Efficacy and Safety of Tarlatamab in a Patient With Advanced Delta-Like Ligand 3-Positive Large Cell Neuroendocrine Lung Carcinoma and Untreated Brain Metastases: A Case Report.

Eleonora Gariazzo, Sanna Laaksonen, Stephanie Canty

|Jan 29, 2025
Practical management of adverse events in patients receiving tarlatamab, a delta-like ligand 3-targeted bispecific T-cell engager immunotherapy, for previously treated small cell lung cancer.

Jacob M Sands, Stéphane Champiat, Horst-Dieter Hummel

Pageof 3

Frequent Collaborators

3 joint publications

Enriqueta Felip

3 joint publications

Aaron Lisberg

2 joint publications

Rebecca S Heist

2 joint publications

David Kozono